Unicycive Therapeutics (UNCY) Short Interest Ratio & Short Volume $4.70 +0.07 (+1.51%) Closing price 04:00 PM EasternExtended Trading$4.62 -0.08 (-1.60%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Unicycive Therapeutics Short Interest DataUnicycive Therapeutics (UNCY) has a short interest of 1.42 million shares, representing 12.91% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 359,606 shares to cover all short positions.Current Short Interest1,420,000 sharesPrevious Short Interest1,420,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$6.16 millionShort Interest Ratio2.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares12,640,000 sharesFloat Size11,000,000 sharesShort Percent of Float12.91%Today's Trading Volume563,583 sharesAverage Trading Volume359,606 sharesToday's Volume Vs. Average157% Short Selling Unicycive Therapeutics? Sign up to receive the latest short interest report for Unicycive Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUNCY Short Interest Over TimeUNCY Days to Cover Over TimeUNCY Percentage of Float Shorted Over Time Unicycive Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,420,000 shares $6.16 million No Change12.9%2 $4.34 7/15/20251,420,000 shares $6.56 million +1,211.2%12.9%2.2 $4.62 6/30/2025108,300 shares $516.59 thousand -70.7%2.9%6.2 $4.77 6/15/2025369,300 shares $2.52 million +3.5%3.5%0.9 $6.81 5/31/2025356,900 shares $209.86 thousand -46.4%0.4%0.2 $0.59 5/15/2025666,100 shares $366.75 thousand -16.0%0.7%0.8 $0.55 4/30/2025793,000 shares $516.72 thousand -23.8%0.8%0.9 $0.65 4/15/20251,040,000 shares $617.34 thousand -39.2%1.1%1.1 $0.59 3/31/20251,710,000 shares $983.08 thousand +12.5%1.7%1.6 $0.57 3/15/20251,520,000 shares $889.20 thousand +8.6%1.8%1.5 $0.59 Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,400,000 shares $770.42 thousand +76.1%1.6%1.3 $0.55 2/15/2025795,200 shares $470.84 thousand -3.4%0.9%0.7 $0.59 1/31/2025823,300 shares $505.34 thousand -51.6%0.9%0.6 $0.61 1/15/20251,700,000 shares $1.14 million +37.1%1.9%1.1 $0.67 12/31/20241,240,000 shares $984.81 thousand +25.4%1.4%0.8 $0.79 12/15/2024989,200 shares $706.78 thousand +18.2%1.1%0.7 $0.71 11/30/2024837,200 shares $576.75 thousand -33.6%1.0%0.5 $0.69 11/15/20241,260,000 shares $579.60 thousand +20.0%1.5%0.8 $0.46 10/31/20241,050,000 shares $561.75 thousand No Change1.2%0.5 $0.54 10/15/20241,050,000 shares $420 thousand +5.7%1.2%0.5 $0.40 9/30/2024993,800 shares $405.37 thousand +158.2%1.2%0.4 $0.41 9/15/2024384,900 shares $152.04 thousand -48.5%0.5%0.1 $0.40 8/31/2024746,800 shares $252.27 thousand -59.4%0.9%0.3 $0.34 8/15/20241,840,000 shares $552 thousand +37.3%2.2%0.9 $0.30 7/31/20241,340,000 shares $585.71 thousand -31.3%2.1%1 $0.44 7/15/20241,950,000 shares $973.05 thousand +32.7%3.1%2 $0.50 6/30/20241,470,000 shares $736.62 thousand +22.5%5.3%2 $0.50 6/15/20241,200,000 shares $778.68 thousand +14.3%4.3%2.3 $0.65 5/31/20241,050,000 shares $924 thousand +22.1%3.4%2.6 $0.88 5/15/2024859,800 shares $928.58 thousand +49.5%3.2%2.3 $1.08 4/30/2024575,000 shares $644.00 thousand +50.2%2.1%1.4 $1.12 4/15/2024382,900 shares $436.51 thousand +49.1%1.5%1 $1.14 3/31/2024256,800 shares $354.38 thousand +352.9%1.0%0.7 $1.38 3/15/202456,700 shares $82.78 thousand +62.0%0.2%0.2 $1.46 2/29/202435,000 shares $48.30 thousand -64.3%0.1%0.1 $1.38 2/15/202498,000 shares $128.38 thousand +46.7%0.4%0.4 $1.31 1/31/202466,800 shares $63.46 thousand -2.8%0.3%0.3 $0.95 1/15/202468,700 shares $57.71 thousand -20.9%0.3%0.4 $0.84 12/31/202386,900 shares $75.40 thousand +1.5%N/A0 $0.87 12/15/202385,600 shares $48.99 thousand +65.6%0.3%0.9 $0.57Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 11/30/202351,700 shares $26.50 thousand -30.0%0.2%0.7 $0.51 11/15/202373,900 shares $38.62 thousand +18.6%0.3%1.4 $0.52 10/31/202362,300 shares $35.53 thousand -42.7%0.3%1.2 $0.57 10/15/2023108,800 shares $93.35 thousand -25.4%0.4%1.9 $0.86 9/30/2023145,800 shares $125.39 thousand +34.5%0.6%2.4 $0.86 9/15/2023108,400 shares $75.05 thousand +71.3%0.4%1.1 $0.69 8/31/202363,300 shares $48.29 thousand -21.0%0.5%0.6 $0.76 8/15/202380,100 shares $60.88 thousand -53.9%0.6%0.6 $0.76 7/31/2023173,800 shares $203.35 thousand -16.0%3.2%1.1 $1.17 7/15/2023206,900 shares $254.49 thousand -15.8%3.8%1 $1.23 6/30/2023245,800 shares $314.62 thousand -10.3%2.7%1 $1.28 6/15/2023274,100 shares $433.08 thousand +8.8%3.0%0.9 $1.58 5/31/2023252,000 shares $332.64 thousand -13.6%2.7%0.1 $1.32 5/15/2023291,800 shares $417.27 thousand +21.7%3.2%0.1 $1.43 4/30/2023239,700 shares $311.61 thousand -8.0%2.6%0 $1.30 4/15/2023260,400 shares $460.91 thousand -34.7%2.9%0 $1.77 3/31/2023398,700 shares $837.27 thousand -71.3%4.4%0.1 $2.10 3/15/20231,390,000 shares $3.07 million +839.2%15.3%0.2 $2.21 2/28/2023148,000 shares $76.52 thousand -17.9%1.6%0 $0.52 2/15/2023180,300 shares $100.97 thousand +55.3%2.0%0.6 $0.56 1/31/2023116,100 shares $65.02 thousand -40.6%1.3%0.4 $0.56 1/15/2023195,600 shares $97.31 thousand -24.5%2.2%0.8 $0.50 12/30/2022259,000 shares $139.86 thousand +284.3%2.9%1.1 $0.54 12/15/202267,400 shares $47.51 thousand +18.5%0.7%2 $0.70 11/30/202256,900 shares $40.52 thousand +4.8%0.6%2 $0.71 11/15/202254,300 shares $38.01 thousand +35.8%0.6%2 $0.70 10/31/202240,000 shares $27.60 thousand -7.4%0.4%1.6 $0.69 10/15/202243,200 shares $24.62 thousand +7.2%0.5%1.3 $0.57 9/30/202240,300 shares $23.78 thousand +53.2%0.4%1.2 $0.59 9/15/202226,300 shares $19.99 thousand -36.0%0.3%0.8 $0.76 8/31/202241,100 shares $28.77 thousand +21.2%0.5%1.2 $0.70 8/15/202233,900 shares $23.74 thousand -62.1%0.4%0.9 $0.70 7/31/202289,500 shares $66.23 thousand +54.6%1.0%2.4 $0.74 7/15/202257,900 shares $46.35 thousand -29.6%0.6%1.9 $0.80 6/30/202282,200 shares $68.23 thousand -12.7%0.9%2.5 $0.83 6/15/202294,200 shares $97.03 thousand +17.3%1.0%2.5 $1.03 5/31/202280,300 shares $71.47 thousand +49.0%0.9%1.3 $0.89 5/15/202253,900 shares $37.73 thousand -39.4%0.6%0.7 $0.70 4/30/202288,900 shares $77.41 thousand +1.5%1.0%1.1 $0.87 4/15/202287,600 shares $94.61 thousand -35.1%1.0%0.7 $1.08 3/31/2022134,900 shares $174.02 thousand +185.8%1.5%0.9 $1.29 3/15/202247,200 shares $50.50 thousand -49.3%0.5%0.3 $1.07 2/28/202293,100 shares $129.41 thousand -22.2%1.0%0.6 $1.39 2/15/2022119,600 shares $160.26 thousand +51.8%1.3%0.7 $1.34 1/31/202278,800 shares $108.74 thousand -49.9%0.9%0.4 $1.38 1/15/2022157,300 shares $281.57 thousand +112.6%1.7%1 $1.79 12/31/202174,000 shares $152.44 thousand +74.5%0.8%0.5 $2.06 12/15/202142,400 shares $95.82 thousand -35.0%0.5%0.3 $2.26 11/30/202165,200 shares $139.53 thousand -7.8%0.7%0.4 $2.14 11/15/202170,700 shares $188.06 thousand -34.9%0.8%0.4 $2.66Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 10/29/2021108,600 shares $313.85 thousand +1.5%1.3%0.6 $2.89 10/15/2021107,000 shares $291.04 thousand +14.2%1.3%0.3 $2.72 9/30/202193,700 shares $265.17 thousand +564.5%1.1%0.1 $2.83 9/15/202114,100 shares $41.03 thousand -78.3%0.2%0 $2.91 8/31/202165,100 shares $188.79 thousand +25.9%0.8%0 $2.90 8/13/202151,700 shares $141.14 thousand No Change0.6%0 $2.73 UNCY Short Interest - Frequently Asked Questions What is Unicycive Therapeutics' current short interest? Short interest is the volume of Unicycive Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 1,420,000 shares of UNCY short. 12.91% of Unicycive Therapeutics' shares are currently sold short. Learn More on Unicycive Therapeutics' current short interest. What is a good short interest ratio for Unicycive Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UNCY shares currently have a short interest ratio of 2.0. Learn More on Unicycive Therapeutics's short interest ratio. What is a good short interest percentage for Unicycive Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.91% of Unicycive Therapeutics' floating shares are currently sold short. What is Unicycive Therapeutics' float size? Unicycive Therapeutics currently has issued a total of 12,640,000 shares. Some of Unicycive Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unicycive Therapeutics currently has a public float of 11,000,000 shares. How does Unicycive Therapeutics' short interest compare to its competitors? 12.91% of Unicycive Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Unicycive Therapeutics: SOPHiA GENETICS SA (0.04%), Y-mAbs Therapeutics, Inc. (6.58%), Editas Medicine, Inc. (9.58%), Eledon Pharmaceuticals, Inc. (8.32%), MediWound Ltd. (11.01%), Aerovate Therapeutics, Inc. (21.72%), Innate Pharma S.A. Sponsored ADR (0.11%), China SXT Pharmaceuticals, Inc. (0.07%), enGene Holdings Inc. (0.05%), GENFIT S.A. Unsponsored ADR (0.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Unicycive Therapeutics stock? Short selling UNCY is an investing strategy that aims to generate trading profit from Unicycive Therapeutics as its price is falling. UNCY shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unicycive Therapeutics? A short squeeze for Unicycive Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UNCY, which in turn drives the price of the stock up even further. How often is Unicycive Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UNCY, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies SOPHiA GENETICS Short Interest Y-mAbs Therapeutics Short Interest Editas Medicine Short Interest Eledon Pharmaceuticals Short Interest MediWound Short Interest Aerovate Therapeutics Short Interest Innate Pharma Short Interest China SXT Pharmaceuticals Short Interest enGene Short Interest GENFIT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UNCY) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access